Regeneron Buys 23andMe in $256M Genetic Data Deal

In one of the biggest shake-ups in the biotech world this year, Regeneron Pharmaceuticals is acquiri

Concord Biotech's Stellar IPO: Subscribed 10.96 Times with Impressive Grey Market Premium

Concord Biotech, a pioneering biotech company backed by Rekha Jhunjhunwala, has witnessed an overwhe